Vitamin K2 with D3
80/100
This product is generally safe
- Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
Label Data
1 Capsule(s)
Serving Size
30
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
125 mcg
(625% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 0.1 mg)
📚 604 studies (Tier A: 16, B: 251)
45 mcg
(38% DV)
✅ Within RDA (0.4× RDA of 0.12 mg)
📚 273 studies (Tier A: 9, B: 175)
Other Ingredients
natural Vegetable Capsules
Microcrystalline Cellulose
Magnesium Stearate
Silicon Dioxide
Stearic Acid
Label Claims — Verification
❓
Nutrient
❓
All Other
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
⚠️ Warnings & Precautions
Warning: All forms of Vitamin K may interact with blood thinning medications. If you are taking such medicines please consult with your physician before taking this product.
🧪 Formulation Notes
Essential Vitamins
Product Details
DSLD Entry Date
2022-09-22
Product Type
Vitamin
Form
Capsule
Brand
Ortho Molecular Products
DSLD ID
277577
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Vitamin D Synergy with Vitamin K1
Designs for Health
100
Natural Vitamin K2 45 mcg
Doctor's Best
100
K 100 mcg
Thompson
100
Vitamin K2 300 mcg MK-7
Innerzyme
100